Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer—findings from the RIBECCA trial

Caroline Anna Peuker, Sarvenaz Yaghobramzi, Corinna Grunert, Luisa Keilholz, Enio Gjerga, Steffen Hennig, Sigrid Schaper, Il‐Kang Na, Ulrich Keller, Sara Y. Brucker, Thomas Decker, Peter A. Fasching, Tanja Fehm, Wolfgang Janni, Sherko Kümmel, Andreas Schneeweiß, Martin Schüler, Diana Lüftner, Antonia Busse